Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nature’s Toolbox has launched commercial-scale benchtop systems—NTxscribe® and NTxpress®—that enable rapid, scalable, high-quality cell-free manufacturing of mRNA/saRNA and recombinant proteins. These platforms have been adopted by leading academic medical centers and major biopharma organizations to accelerate the development of personalized medicines, vaccines, and biologics. The company does not develop its own clinical-stage therapeutics but empowers others to do so with its technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nature's Toolbox.